Safety data from the phase III Japanese ACHIEVE trial: part of an international, prospective, planned pooled analysis of six phase III trials comparing 3 versus 6 months of oxaliplatin-based adjuvant chemotherapy for stage III colon cancer.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Manabu Shiozawa Dai Manaka Shigetoyo Saji Hiroyuki Bando Yoshinori Munemoto Akinori Takagane Makio Gamoh Masahito Kotaka Tsunekazu Mizushima Masato Nakamura Takeharu Yamanaka Junichi Hasegawa Yoshihiko Maehara Takayuki Yoshino Atsushi Ohtsu Tetsuya Eto |
| Publication date | April 24, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |